This report presents an orgonomic interpretation of cancer pathogenesis, focusing on the bioenergetic processes underlying the formation of cancer cells. Based on microscopic observations, the cancer process is described as a two-phase cycle that starts with cellular energy depletion and vesicular reorganization. The study introduces experimental cytological, blood-based, and thermal tests for ultra-early cancer detection.

1. Introduction
Cancer remains one of the most challenging diseases in contemporary medicine. While conventional oncology targets the cancer cell as the primary cause, this talk explores an alternative model rooted in bioenergetic theory. Here, cancer is seen as a consequence of chronic energy depletion within cells, leading to a predictable series of structural transformations.

2. Bioenergetic decline and cellular degeneration
2.1 Relationship Between Bioenergy and Health
Health correlates directly with the organism’s bioenergetic charge. A reduction in energy parallels a decline in physiological function, similar to how decreased financial income leads to a lower standard of living of people.

2.2 Microscopic observations
Microscopic analysis reveals that cells from energy-depleted organisms exhibit marked morphological changes. These changes provide insight into the mechanisms underlying cancer development.

3. The two-phase cancer process
3.1 Phase 1. Vesicular reaction and cellular reorganization
3.1.1 Vesicle formation (Ca I stage)
A healthy cell is shown in figure 1.

Figure 1 – Healthy cell (400x microscope)

Cell undergoing energy depletion forms intracellular vesicles that are initially distributed homogeneously. Figure 1a shows a cell with intracellular vesicles homogeneously distributed.

Figure 1a – Cell with intracellular vesicles homogeneously distributed (400x microscope)

Then, vesicles aggregate towards the cellular periphery (figure 1b).

Figure 1b – Vesicles accumulating towards the cell periphery (400x microscope)

3.1.2 Vesicle aggregation (Ca II stage)
Vesicles aggregate towards the cellular periphery thus forming dense clusters. Figure 2a through 2d show a vesicular reaction in Ca II Cells.

3.1.3 Formation of club-shaped cells (Ca III stage)
Aggregated vesicles reorganize into entirely new structures, termed club cells (Ca III), absent in healthy tissue. These cells precede the formation of the tumor mass and serve as early diagnostic markers. Figure 3a through 3d show club-shaped Ca III cells

3.1.4 Tumor mass formation
Progression from Ca I to Ca III stage culminates in the development of a solid tumor mass (phase 2).

3.2 Phase 2. Necrosis and T-bacilli proliferation
3.2.1 Tumor cell necrosis
As tumor cells reach maximal maturation, they undergo rapid aging and die in large numbers, leading to necrosis.

3.2.2 Emergence of T-bacilli
Necrotic tumor tissues give rise to specific microorganisms known as T-bacilli (figure 4), as originally described by Reich (1). These Gram-negative bacilli (0.2-0.3 microns) are characterized by their ability to induce vesicular reactions in adjacent healthy cells, perpetuating the cancer cycle. T-bacilli are not currently known by mainstream biology.

Figure 4 – T-bacilli (dark field 400x)

3.2.3 Exponential disease progression
Completion of phase 1 and 2 results in an exponential increase of T-bacilli population, leading to severe systemic intoxication of the organism, cachexia, and ultimately, patient death.

4. Diagnostic Approaches
4.1 Cytological test
Direct microscopic identification of Ca I, Ca II, and Ca III cells enables ultra-early cancer formation detection.

Figure 5 – Cytological identification of Ca I, Ca II, and Ca III cells

4.2 Reich Blood Test
This test determines the bio-energetic or life-energy charge of blood samples, differentiating between high-energy (figure 6a) and depleted (figure 6b) states.

4.3 Autoclave Test
Exposure of blood samples to thermal stress reveals their energetic resilience, offering an additional diagnostic tool.

5. Tumor Angiogenesis. An Orgonomic View
Angiogenesis is orgonomically interpreted as a bioenergetic interaction between blood and tumor mass. If the blood is energetically stronger, the tumor can be reabsorbed. The red blood cells, being more energetically-charged than the tumor mass, withdraw energy from the cancer cells (figure 8).

Figure 8 – Bioenergetic imbalance between blood (stronger) and tumour mass (weaker)

Conversely, if the blood is energetically weaker the disease progresses. Bio-energy is withdrawn from the less charged red blood cells by the tumor mass.

Figure 9 – Bioenergetic imbalance between blood (weaker) and tumour mass (stronger)

6. Implications for the therapy
Current therapeutic strategies directly targeting cancer cells are likely to fail, as they address the consequence rather than the cause of the disease. Effective intervention should focus on restoring the organism’s bioenergetic charge and preventing vesicular reorganization.

7. Summary and Conclusions
1. The cancer cell is not the cause of cancer. It is a by-product of the vesicular reorganization.
2. Cancer develops through two distinct but interrelated phases: formation of Ca I-Ca II-Ca III cells and tumor mass (phase 1), followed by necrosis and T-bacilli proliferation (phase 2).
3. Having the same precursors, all solid tumors have a common origin and therefore it is a unique disease that manifests itself differently depending on the environment in which it develops.
4. Therapies targeting cancer cells are insufficient. Focus must shift to underlying bioenergetic factors.
5. Death results from systemic intoxication caused by T-bacilli, not solely from tumor burden.

References
1. Reich, W. (1948). The Cancer Biopathy. Volume I & II, Orgone Institute Press, New York.
2. Vecchietti, A. (2025). Personal observations. See also www.cellulacancerosa.it.